ASBP is trading at $6.05, down 6.2%, as the stock extends a pullback following its recent BUZZ BOMB Amazon launch and planned Life Sciences Investor Forum presentation.
- The decline follows a short-term rally driven by the product launch and anticipation surrounding the upcoming investor forum.
- Broader weakness in US equity futures is weighing on the stock, with major indices trading modestly lower.
- The price action suggests a combination of post-news consolidation and general risk-off sentiment in early trading.